IL1R2 and atherosclerosis: Many studies reported that the IL1R2 as a protected factor can decrease the risk of many diseases, such as IgA nephropathy (Xie et al., 2017), Arthritis (Shimizu et al., 2015), and atherosclerosis (Pou et al., 2011).